The Global Bioabsorbable Stent/Bioresorbable Scaffold Market was valued at USD 222.84 million in 2016 and is projected to reach USD 586.41 million by 2025, growing at a CAGR of 11.1% from 2017 to 2025.
A stent is any device which is inserted into a blood vessel or other internal duct in order to expand the vessel to prevent or alleviate a blockage.A bioresorbable stent, (also called biodegradable or naturally-dissolving) serves the same purpose, but is manufactured from a material that may dissolve or be absorbed in the body. The demand in market has increased because of the long term benefits which are not provided by traditional stents.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Non fluctuating Demands in Market
1.2 Growing demand for in older age group due to risk of CAD and PAD
2. Market Restraints
2.1 Competition provided by substitutes
Market Segmentation:
1. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by Absorption Rate:
1.1 Slow Absorption rate
1.2 Fast absorption rate
2. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by Material:
2.1 Bioresorbable Polymer-Based Stents
2.2 Bioresorbable Metallic Stents
3. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by End User:
3.1 Hospitals
3.2 Cardiac Centers
4. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by Application:
4.1 Coronary Artery Disease
4.2 Peripheral Artery Disease
5. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Abbott
2. REVA Medical, Inc.
3. Elixir Medical Corporation
4. KYOTO MEDICAL PLANNING Co., Ltd.
5. BIOTRONIK
6. Amaranth Medical, Inc.
7. Arterial Remodeling Technologies
8. Meril Life Sciences Pvt. Ltd.
9. Arterius Limited
10. LEPU MEDICAL TECHNOLOGY CO., LTD.
11. Boston Scientific Corporation
12. 480 Biomedical
13. S3V Vascular Technologies Private Limited
14. Qualimed (Part of Q3 Medical Group)
15. ORBUSNEICH
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Bioabsorbable Stent/Bioresorbable Scaffold Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY ABSORPTION RATE
5.1 Slow Absorption rate
5.2 Fast absorption rate
6 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY MATERIAL
6.1 Bioresorbable Polymer-Based Stents
6.2 Bioresorbable Metallic Stents
7 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY END USER
7.1 Hospitals
7.2 Cardiac Centers
8 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY APPLICATION
8.1 Coronary Artery Disease
8.2 Peripheral Artery Disease
9 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
10 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Abbott
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 REVA Medical, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Elixir Medical Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Kyoto Medical Planning Co., Ltd.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 BIOTRONIK
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Amaranth Medical, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Arterial Remodeling Technologies
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Meril Life Sciences Pvt. Ltd.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Arterius Limited
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 LEPU MEDICAL TECHNOLOGY CO., LTD.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 Boston Scientific Corporation
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 480 Biomedical
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments
11.13 S3V Vascular Technologies Private Limited
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments
11.14 Qualimed
11.14.1 Overview
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Developments
11.15 ORBUSNEICH
11.15.1 Overview
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Developments
12 Appendix
12.1 Related Reports
The Scaffold Free 3D Stem Cell Culture Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Coronary Stent Delivery System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The global Peripheral Stent Systems market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Scaffold Technology market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Neurovascular Stent Retrievers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market playe...
The global Metal Neurovascular Stent Retrievers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market...
The global Polymer Neurovascular Stent Retrievers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mark...
The global Balloon-expandable Vascular Stent market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...
The global Drug-Eluting Bioabsorbable Stents market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...
The global Uterine Stent market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field ...